Načítá se...
Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy
BACKGROUND: Anti-TNFa medications represent the first effective biologic therapy for IBD that has largely revolutionized treatment. The aim of this study was to quantify the risk of MM and other skin cancers among patients from Northern Greece area with IBD who take immunosuppressive or biologic ant...
Uloženo v:
| Vydáno v: | Asian Pac J Cancer Prev |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
West Asia Organization for Cancer Prevention
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6291021/ https://ncbi.nlm.nih.gov/pubmed/30362311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.10.2845 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|